High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$14.9M
$14,924,550
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2026-02-25 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $2,707,813Largex5 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Equity Compensation
|
2025-12-17 | $99,985x2 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Equity Compensation
|
2025-12-08 | $208,000x2 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Mainolfi Nello
• CEO
10b5-1 SellΔOwn -13.2%
2025-12-08
$8,917,000Whale
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -13.2%
|
2025-12-08 | $8,917,000Whale | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2025-10-29 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-29 | $1,829,737Largex3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
Other
|
2025-09-16 | $62,400 | M | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-16 | $1,470,000Large | S | Form 4 |